Luciana Ferreira Antunes

Luciana Ferreira Antunes

Auto-generated profile, based on publicly available information

Luciana Ferreira Antunes

Faculdade Santa Casa de Belo Horizonte REVISTA CIENTÍFICA -RECIMA21

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025 in Journal of Molecular and Clinical Medicine
Verified
Journal Article
Open access
LALuciana Ferreira Antunes
Luciana Ferreira Antunes
RSRegiane Penaforte Santos
Regiane Penaforte Santos
JCJúlia Vieira Carvalho
Júlia Vieira Carvalho
PCPaulo Pereira Christo
Paulo Pereira Christo
PDPedro Henrique Villar Delfino
Pedro Henrique Villar Delfino
CVCaroline Maria Oliveira Volpe
Caroline Maria Oliveira Volpe
Background: Multiple sclerosis (MS) is a neurological disorder that is directly linked to inflammation in the central nervous system (CNS). The activation of toll-like receptors (TLRs) exacerbates neuroinflammation by increasing the production of reactive oxygen species (ROS) and proinflammatory cytokines. Edaravone (EDV) has been proposed as a potential therapy for CNS diseases because of its free radical scavenging and anti-inflammatory properties. This study investigated the effects of EDV on the inflammatory response in TLR4-stimulated peripheral blood mononuclear cells (PBMNCs) from MS patients and a healthy control group. Methods: The impact of EDV on ROS production in lipopolysaccharide (LPS)-stimulated PBMNCs was assessed using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) reduction and luminol-dependent chemiluminescence assays. The interleukin (IL)-6 concentration in the PBMNC supernatants was measured using enzyme-linked immunosorbent assay (ELISA). Results: The results showed that ROS production in PBMNCs stimulated using LPS (a TLR4 activator) was significantly inhibited (p < 0.05) by EDV in the MS patients and control group. Additionally, EDV significantly reduced IL-6 secretion in TLR4-stimulated PBMNCs in these groups (p < 0.05). No significant differences were observed between the groups. Conclusion: Our findings suggest that EDV may serve as an adjunctive therapy for MS by reducing ROS and IL-6 production in TLR4-stimulated PBMNCs in MS patients, highlighting its potential in modulating neuroinflammation and oxidative stress.

1 August 2025 in RECIMA21 - Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
CTCalina Maria Loures De Oliveira Teixeira
Calina Maria Loures De Oliveira Teixeira
LALuciana Ferreira Antunes
Luciana Ferreira Antunes
CVCaroline Maria Oliveira Volpe
Caroline Maria Oliveira Volpe
Objetivos: Detectar se há concentração de melatonina no colostro materno e assim endossar a amamentação materna exclusiva, tendo em vista o hormônio não ser encontrado para comercialização ou em fórmulas lácteas artificiais. Métodos: Dosagem de melatonina no colostro materno coletados no período pós-parto, entre 7-10 horas da manhã, e quantificados através da técnica de ELISA. Resultados: o estudo incluiu 41 puérperas (19-40 anos, gestação de 35-41 semanas). Nenhuma das pacientes observadas apresentou infecções ou descompensação puerperal. A via de parto não demonstrou influência nos níveis de melatonina. Conclusões: Encontramos a presença de melatonina no colostro materno. Não houve correlação com a via de parto.